Germline mutations in TP53 predispose people to Li–Fraumeni syndrome (LFS), which is characterized by early onset of cancers, including breast cancer, sarcomas, brain tumors, leukemia, and adrenocortical carcinomas [8,9,10]. The gene discussed is TP53; the disease is cancer.